Product Data Sheet

KRAS G12C inhibitor 23

Catalog No. A63674

main product photo
KRAS G12C inhibitor 23 is a selective inhibitor targeting the KRAS G12C mutation. It effectively inhibits H358 cells with an IC50 value of 491 nM, demonstrating its potential in cancer research. This compound is primarily utilized in studies focused on KRAS-driven cancers for therapeutic development and efficacy evaluation.
Chemical Information
Catalog NumA63674
M. Wt553.63
FormulaC32H32FN5O3
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2735721-00-1
Synonyms
SMILESO=C1N(C2=C(N=CC=C2C)C(C)C)C3=C(OCC4=CC=CC=C45)C5=C(F)C=C3C(N6[C@H](CN(CC6)C(C=C)=O)C)=N1
Biological Activity
DescriptionKRAS G12C inhibitor 23 is a selective inhibitor targeting the KRAS G12C mutation. It effectively inhibits H358 cells with an IC50 value of 491 nM, demonstrating its potential in cancer research. This compound is primarily utilized in studies focused on KRAS-driven cancers for therapeutic development and efficacy evaluation.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.